Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (75)

Latest Posts

About This Stock More About This Stock
AskSlim Market Week - 01/06/17
Video By: Steve Miller
Friday, January 6, 2017 10:00 PM EST
Stock market continuing its upward move really worldwide as the buyers pick up where they left off in 2016. Ofcourse, a little stalling at the end of the year, but then we saw the market buyers come back.
In this video: AMGN, AMZN, BABA, BIDU, DBB, FB, FCX, GLD, KSS, NFLX, OIL, PAAS, SCHN, SHLD, SLV, SPX, TLT, USO, UUP
Watch
Mean Reversion And The Bell Curve
Article By: Bill Smead
Tuesday, January 3, 2017 3:28 PM EST
Over a three-year time period, stock prices tend to mean revert. This has spawned numerous investment approaches which try to squeeze capital gains out of those reversions.
In this article: AMGN, AXP, ESRX
Read
Merck (MRK) Does Well In 2016: Reasons For Outperformance
Article By: Zacks Investment Research
Sunday, January 1, 2017 6:09 PM EST
Like many of its peers, Merck is facing generic competition and pricing pressure for some products. Yet, we believe its diversified business model, deep pipeline and strong financial position will continue to help the company navigate tough times.
In this article: AMGN, GSK, MRK, PFE
Read
EC Gilead Is A Hail Mary: 3 Better Stocks To Consider
Article By: Blue Harbinger
Friday, December 23, 2016 12:21 PM EST
We believe uncertainty and under-performance have created attractive opportunities for contrarian value-focused investors, such as the three opportunities described in this article.
In this article: AMGN, LLY, BMY Also: PFE, GILD
Read
The FDA: Small-Cap Catalyst Or Small-Cap Killer?
Article By: Wall Street Daily
Friday, December 16, 2016 9:37 AM EST
This particular bureaucracy neither gives nor takes. Data do. If a drug works, the company that develops it will do well. If a drug doesn’t work, the company that develops it had better have a diversified pipeline.
In this article: BMY, LLY, MRK, PFE, AMGN, CORT, VYGR, SRPT, VCEL, AKAO, CERC, PRTO, OPHT
Read

PARTNER HEADLINES

Latest Tweets for $AMGN

No tweets yet!